About AIA Australia
AIA Australia is a leading independent life insurance specialist with over 45 years’ experience. With a unique customer value proposition focused on life, health and wellbeing, our purpose is to make a difference in people’s lives.
AIA Australia offers a range of products that protect and enhance the lives of more than four million Australians. Our vision is to embrace shared value in championing Australia and New Zealand to be the healthiest and most protected nations in the world. With AIA Vitality – the world’s leading scientifically-backed health and wellbeing programme – we help members to live healthier, longer, better lives.
AIA Australia has been recognised with multiple awards, including being named ANZIIF Life Insurance Company of the Year (2017, 2015, 2013, 2012). Further information at www.aia.com.au.
About AIA New Zealand
In New Zealand AIA and Sovereign together employ almost 900 people. Since AIA arrived in New Zealand in 1981, it has consistently provided the market with innovative personal and business insurance products that suit the Kiwi way of life. In July 2018, the AIA Group acquired Sovereign, becoming the largest life insurer in New Zealand. AIA and Sovereign offer a complete range of risk management products that focus on the needs of customers. The companies are both based in Auckland, with regional offices in Hamilton, Wellington and Christchurch. Both companies are members of the Insurance and Financial Services Ombudsman Scheme and the Health Funds Association of New Zealand. AIA has an insurer financial strength rating from Standard and Poor’s of AA-. Sovereign has a rating of A+, from AM Best.
About Medibio Limited
Medibio (ASX: MEB) (OTCQB: MDBIF) is a mental health technology company that has pioneered the use of objective digital biomarkers to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in Australia, with offices located in Melbourne (Vic), Perth (WA) and U.S. offices in Minneapolis, MN. Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market. Investors can find additional information on www.otcmarkets.com and www.asx.com.au. Website: www.medibio.com.au.